Humasis ranked among the top searched stocks on 5 days within the past month.


As of 12:30 PM on the 11th, Humasis is trading at 14,550 KRW, down 1.02% from the previous day. This represents a 17.34% increase compared to September 4. Humasis is known as an in vitro diagnostic device company.

Over the past 5 days, individual investors have net purchased 137,975 shares, while foreigners and institutions have net purchased 2,862 shares and net sold 756 shares, respectively.


On September 9, Humasis became a market issue with a "16% increase due to approval for export of COVID-19 antigen test kits."



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing